Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study

Authors Information
Article Notes and Dates
To Cite : Chen P, Yu C, Wu W, Wang J, Ruan B, et al. Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study, Hepat Mon. 2013 ;13(1):e7604. doi: 10.5812/hepatmon.7604.
Copyright: Copyright © 2013, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol. 2011; 17(38): 4258-70[DOI][PubMed]
  • 2. Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol. 2011; 17(44): 4853-7[DOI][PubMed]
  • 3. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009; 27(47): 6550-7[DOI][PubMed]
  • 4. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009; 373(9663): 582-92[DOI][PubMed]
  • 5. Liaw YF. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009; 29 Suppl 1: 100-7[DOI][PubMed]
  • 6. Li T, Du H, Zhang HY. HBV genotype and its association to chronic HBV infection in Beijing. China. J Gastroenterol Hepatol. 2004; 19
  • 7. Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur J Gastroenterol Hepatol. 2011; 23(8): 695-700[DOI][PubMed]
  • 8. Xia GL, Liu CB, Cao HL, Bi SL, Zhan MY, Su CA, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996; 5(1): 62-73[DOI]
  • 9. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002; 35(6): 1522-7[DOI][PubMed]
  • 10. Liaw YF. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol. 2003; 18(3): 246-52[PubMed]
  • 11. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002; 347(3): 168-74[DOI][PubMed]
  • 12. Chan HL, Leung NW, Hussain M, Wong ML, Lok AS. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology. 2000; 31(3): 763-8[DOI][PubMed]
  • 13. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987; 92(6): 1839-43[PubMed]
  • 14. Carman WF, Hadziyannis S, McGarvey MJ, Jacyna MR, Karayiannis P, Makris A, et al. MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION. Lancet. 1989; 334(8663): 588-91[DOI]
  • 15. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB. Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol. 2009; 81(12): 1999-2006[DOI][PubMed]
  • 16. Zarski JP. Épidémiologie de l’hépatite chronique B. La Presse Médicale. 2006; 35(2, Part 2): 304-7[DOI]
  • 17. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001; 135(9): 759-68[PubMed]
  • 18. Abebe A, Nokes DJ, Dejene A, Enquselassie F, Messele T, Cutts FT. Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control. Epidemiol Infect. 2003; 131(1): 757-70[PubMed]
  • 19. Tsai NC, Holck PS, Wong LL, Ricalde AA. Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii. Hepatol Int. 2008; 2(4): 478-85[DOI][PubMed]
  • 20. Jardi R, Buti M, Rodriguez-Frias F, Cortina M, Esteban R, Guardia J, et al. The value of quantiative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol. 1996; 24(6): 680-5
  • 21. Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, et al. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. Southeast Asian J Trop Med Public Health. 2002; 33(1): 110-7[PubMed]
  • 22. Rabbi FJ, Rezwan MK, Shirin T. HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers. Bangladesh Med Res Counc Bull. 2008; 34(2): 39-43[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check